Search research articles
Contact Us
Filters
Showing results (301-310 of 423) with videos related to
Page
of 43
Sort By:
Annals of Surgical Oncology
|
July 26, 2013
Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines
Jennifer C Carr, Philip M Spanheimer, Maheen Rajput, et al.
Eating and Weight Disorders : EWD
|
December 15, 2010
Naturalistic study of course, effectiveness, and predictors of outcome among female adolescents in residential treatment for eating disorders
S S Delinsky, S A St Germain, J J Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1982
Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase
T A Slotkin, A Grignolo, W L Whitmore, et al.
Journal of the American College of Surgeons
|
June 26, 2026
Assessing Quality of Colorectal Cancer Care at Commission on Cancer Accredited Hospitals
Joseph H Cotler, Amy J Sachs, Amanda E Browner, et al.
Journal of the American Veterinary Medical Association
|
August 5, 2008
Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs
Robert Six, Judy Cherni, Robert Chesebrough, et al.
Blood
|
July 4, 2007
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
Patricia A Taylor, Michael J Ehrhardt, Christopher J Lees, et al.
Oncogene
|
September 12, 2012
Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer
M V Kulak, A R Cyr, G W Woodfield, et al.
Annals of Surgical Oncology
|
May 15, 2015
Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer
Philip M Spanheimer, Allison W Lorenzen, James P De Andrade, et al.
Pediatric Blood & Cancer
|
April 28, 2017
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)
James I Geller, John P Perentesis, Xiaowei Liu, et al.
Pediatric Blood & Cancer
|
October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group
Michael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Page
of 43
Search research articles
Search
Showing results (301-310 of 423) with videos related to
Sort By:
Page
of 43
Annals of Surgical Oncology
|
July 26, 2013
Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines
Jennifer C Carr, Philip M Spanheimer, Maheen Rajput, et al.
Eating and Weight Disorders : EWD
|
December 15, 2010
Naturalistic study of course, effectiveness, and predictors of outcome among female adolescents in residential treatment for eating disorders
S S Delinsky, S A St Germain, J J Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1982
Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase
T A Slotkin, A Grignolo, W L Whitmore, et al.
Journal of the American College of Surgeons
|
June 26, 2026
Assessing Quality of Colorectal Cancer Care at Commission on Cancer Accredited Hospitals
Joseph H Cotler, Amy J Sachs, Amanda E Browner, et al.
Journal of the American Veterinary Medical Association
|
August 5, 2008
Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs
Robert Six, Judy Cherni, Robert Chesebrough, et al.
Blood
|
July 4, 2007
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
Patricia A Taylor, Michael J Ehrhardt, Christopher J Lees, et al.
Oncogene
|
September 12, 2012
Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer
M V Kulak, A R Cyr, G W Woodfield, et al.
Annals of Surgical Oncology
|
May 15, 2015
Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer
Philip M Spanheimer, Allison W Lorenzen, James P De Andrade, et al.
Pediatric Blood & Cancer
|
April 28, 2017
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)
James I Geller, John P Perentesis, Xiaowei Liu, et al.
Pediatric Blood & Cancer
|
October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group
Michael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Page
of 43